Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J T Cross

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
The Pharmacogenomics Journal|January 16, 2008
A review of gene-drug interactions for nonsteroidal anti-inflammatory drug use in preventing colorectal neoplasiaJ T Cross, E M Poole, C M Ulrich
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 1, 1994
Streptomycin and alternative agents for the treatment of tularemia: review of the literatureG Enderlin, L Morales, R F Jacobs, et al.
Current Medical Research and Opinion|June 15, 2007
The cost of treating ribavirin-induced anemia in hepatitis C: the impact of using recombinant human erythropoietinE B Devine, J T Cross, K V Kowdley, et al.
Clinical Pharmacology and Therapeutics|February 4, 2011
Can modeling of health outcomes facilitate regulatory decision making? The benefit-risk tradeoff for rosiglitazone in 1999 vs. 2007J T Cross, D L Veenstra, J S Gardner, et al.
International Journal of STD & AIDS|November 13, 2004
Health literacy and patient knowledge in a Southern US HIV clinicM S Wolf, T C Davis, J T Cross, et al.
Pediatrics|February 7, 2001
Childhood vaccine risk/benefit communication in private practice office settings: a national surveyT C Davis, D D Fredrickson, C L Arnold, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
The Pharmacogenomics Journal|January 16, 2008
A review of gene-drug interactions for nonsteroidal anti-inflammatory drug use in preventing colorectal neoplasiaJ T Cross, E M Poole, C M Ulrich
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 1, 1994
Streptomycin and alternative agents for the treatment of tularemia: review of the literatureG Enderlin, L Morales, R F Jacobs, et al.
Current Medical Research and Opinion|June 15, 2007
The cost of treating ribavirin-induced anemia in hepatitis C: the impact of using recombinant human erythropoietinE B Devine, J T Cross, K V Kowdley, et al.
Clinical Pharmacology and Therapeutics|February 4, 2011
Can modeling of health outcomes facilitate regulatory decision making? The benefit-risk tradeoff for rosiglitazone in 1999 vs. 2007J T Cross, D L Veenstra, J S Gardner, et al.
International Journal of STD & AIDS|November 13, 2004
Health literacy and patient knowledge in a Southern US HIV clinicM S Wolf, T C Davis, J T Cross, et al.
Pediatrics|February 7, 2001
Childhood vaccine risk/benefit communication in private practice office settings: a national surveyT C Davis, D D Fredrickson, C L Arnold, et al.
Pageof 2